Perspectives for antitumor therapy based on the recognition mechanism by which macrophages identify undesirable foreign and native cells and molecules

Anticancer Research

Volumn 22, Issue 6 C, 2002, Pages 4277-4280

  Takiguchi, Kunio ^a   Inagawa, Hiroyuki ^b   Nishizawa, Takashi ^b   Kohchi, Chie ^c   Soma, Gen Ichiro ^b  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Innate immunity; Lipopolysaccharide; Macrophages; Recognition systems; Toll like receptors

Indexed keywords

LIPOPOLYSACCHARIDE; NITRIC OXIDE; TOLL LIKE RECEPTOR;

ANTIGEN RECOGNITION; ANTIGENICITY; CANCER THERAPY; CONFERENCE PAPER; FOREIGN BODY; HUMAN; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MACROPHAGES; NEOPLASMS;

EID: 0036875405     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Kawakami Y: Immunotherapy using T cell defined tumor antigens for melanoma. Microbiol Immunol 42: 801-813, 1998.
2. Disis ML and Cheever MA: HER-2/neu oncogenic protein: issues in vaccine development. Crit Rev Immunol 18: 37-45, 1998.
3. Azuma I and Seya T: Development of immunoadjuvants for immunotherapy of cancer. Int Immunopharmacol 1: 1249-1259, 2001.
4. Metchnikoff E: Lecons Sur la Pathologie Comparee de L'inflammation. Paris, Masson, 1892.
5. Carr I: The fine structure of the mammalian lymphoreticular system. Int Rev Cytol 27: 283-348, 1970.
6. Aderem A and Underhill DM: Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17: 593-623, 1999.
7. Akira S, Takeda K and Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2: 675-680, 2001.
8. Bowie A and O'Neill LA: The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol 67: 508-514, 2000.
9. Elomaa O, Sankala M, Pikkarainen T, Bergmann U, Tuuttila A, Raatikainen-Ahokas A, Sariola H and Tryggvason K: Structure of the human macrophage MARCO receptor and characterization of its bacteria-binding region. J Biol Chem 273: 4530-4538, 1998.
10. Hallman M, Ramet M and Ezekowitz RA: Toll-like receptors as sensors of pathogens. Pediatr Res 50: 315-321, 2001.
11. Peiser L and Gordon S: The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation. Microbes Infect 3: 149-159, 201.
12. Ulevitch RJ and Tobias PS: Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 11: 19-22, 1999.
13. Antal-Szalmas P: Evaluation of CD14 in host defence. Eur J Clin Invest 30: 167-179, 2000.
14. Chan A, Magnus T and Gold R: Phagocytosis of apoptotic inflammatory cells by microglia and modulation by different cytokines: mechanism for removal of apoptotic cells in the inflamed nervous system. Glia 33: 87-95, 2001.
15. Witting A, Muller P, Herrmann A, Kettenmann H and Nolte C: Phagocytic clearance of apoptotic neurons by Microglia/Brain macrophages in vitro: involvement of lectin-, integrin-, and phosphatidylserine-mediated recognition. J Neurochem 75: 1060-1070, 2000.
16. Boullier A, Bird DA, Chang MK, Dennis EA, Friedman P, Gillotre-Taylor K, Horkko S, Palinski W, Quehenberger O, Shaw P, Steinberg D, Terpstra V and Witztum JL: Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci 947: 214-222; discussion 222-213, 2001.
17. Shiratsuchi A and Nakanishi Y: Phosphatidylserine-mediated phagocytosis of anticancer drug-treated cells by macrophages. J Biochem (Tokyo) 126: 1101-1106, 1999.
18. Gregory CD: CD14-dependent clearance of apoptotic cells: relevance to the immune system. Curr Opin Immunol 12: 27-34, 2000.
19. Peiser L, Gough PJ, Kodama T and Gordon S: Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect Immun 68: 1953-1963, 2000.
20. Wintergerst ES, Jelk J and Asmis R: Differential expression of CD14, CD36 and the LDL receptor on human monocyte-derived macrophages. A novel cell culture system to study macrophage differentiation and heterogeneity. Histochem Cell Biol 110: 231-241, 1998.
21. Imachi H, Murao K, Hiramine C, Sayo Y, Sato M, Hosokawa H, Ishida T, Kodama T, Quehenberger O, Steinberg D and Takahara J: Human scavenger receptor B1 is involved in recognition of apoptotic thymocytes by thymic nurse cells. Lab Invest 80: 263-270, 2000.
22. Kaul M and Loos M: Collagen-like complement component C1q is a membrane protein of human monocyte-derived macrophages that mediates endocytosis. J Immunol 155: 5795-5802, 1995.
23. Tenner AJ, Robinson SL and Ezekowitz RA: Mannose binding prolein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 M(r) component of the C1q receptor. Immunity 3: 485-493, 1995.
24. Levitz SM and Tabuni A: Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin. J Clin Invest 87: 528-535, 1991.
25. Ehlers MR: CR3: a general purpose adhesion-recognition receptor essential for innate immunity. Microbes Infect 2: 289-294, 2000.
26. Smith PD, Smythies LE, Mosteller-Barnum M, Sibley DA, Russell MW, Merger M, Sellers MT, Orenstein JM, Shimada T, Graham MF and Kubagawa H: Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 167: 2651-2656, 2001.
27. Tino MJ and Wright JR: Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am J Physiol 270: L677-688, 1996.
28. Avni O, Pur Z, Yefenof E and Baniyash M: Complement receptor 3 of macrophages is associated with galectin-1-like protein. J Immunol 160: 6151-6158, 1998.
29. Hoffmann JA, Kafatos FC, Janeway CA and Ezekowitz RA: Phylogenetic perspectives in innate immunity. Science 284: 1313-1318, 1999.
30. Means TK, Golenbock DT and Fenton MJ: The biology of Toll-like receptors. Cytokine Growth Factor Rev 11: 219-232, 2000.
31. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K and Akira S: Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002.
32. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM and Aderem A: The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099-1103, 2001.
33. Beutler B: Endotoxin, toll-like receptor 4, and the afferent limb of innate immunity. Curr Opin Microbiol 3: 23-28, 2000.
34. Kaisho T and Akira S: Toll-like receptors and their signaling mechanism in innate immunity. Acta Odontol Scand 59: 124-130, 2001.
35. Lien E and Ingalls RR: Toll-like receptors. Crit Care Med 30: S1-11, 2002.
36. Takeuchi O and Akira S: Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol 1: 625-635, 2001.
37. Shoham S, Huang C, Chen JM, Golenbock DT and Levitz SM: Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J Immunol 166: 4620-4626, 2001.
38. Ohashi K, Burkart V, Flohe S and Kolb H: Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164: 558-561, 2000.
39. Perera PY, Mayadas TN, Takeuchi O, Akira S, Zaks-Zilberman M, Goyert SM and Vogel SN: CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 166: 574-581, 2001.
40. Tobias PS, Soldau K, Iovine NM, Elsbach P and Weiss J: Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS. J Biol Chem 272: 18682-18685, 1997.
41. Means TK, Golenbock DT and Fenton MJ: Structure and function of Toll-like receptor proteins. Life Sci 68: 241-258, 2000.
42. Cusumano V, Tufano MA, Mancuso G, Carbone M, Rossano F, Fera MT, Ciliberti FA, Ruocco E, Merendino RA and Teti G: Porins of Pseudomonas aeruginosa induce release of tumor necrosis factor alpha and interleukin-6 by human leukocytes. Infect Immun 65: 1683-1687, 1997.
43. Itami T, Ohno Y, Suzuki N, Doi K, Kondo, M, Takahashi Y, Maeda M, Soma G-I, Inagawa H, Honda T and Yokomizo Y: Superoxide and nitric oxide production of Kuruma shrimp (Marsupenaeus japonicus) hemocytes. Fishery Sciences, in press.
44. Tsukioka D, Nishizawa T, Miyase T, Achiwa K, Suda T, Soma G and Mizuno D: Structural characterization of lipid A obtained from Pantoea agglomerans lipopolysaccharide. FEMS Microbiol Lett 149: 239-244, 1997.
45. Fearon DT: Seeking wisdom in innate immunity. Nature 388: 323-324, 1997.